MigraineMind research summary

Migraine in Multiple Sclerosis: Underlying Mechanisms, Shared Symptoms, and Approaches to Management.

Int J MS Care | 2025

Review
AuthorsThevar P, Butzkueven H, Ray J, McIlroy A, Hutton E
JournalInt J MS Care
Publication year2025
PubMed ID42903024

Summary

Migraine is common in people with relapsing-remitting multiple sclerosis (MS). About 50% of individuals with MS also experience migraines. Having both conditions can worsen symptoms and increase relapse risks. This study reviews how migraines and MS are linked. It explores biological mechanisms behind both conditions. The research highlights inflammation and brain lesions as contributing factors. It also examines how psychological and cognitive symptoms affect patients. Treatment options for migraines in MS patients are discussed. The study finds that existing MS treatments may worsen migraines. It emphasizes the importance of understanding these connections to improve patient care. By addressing both conditions together, healthcare providers can better manage symptoms. This research aims to enhance the quality of life for those affected by both migraines and MS. Clinical relevance: Understanding the links between migraine and MS can improve treatment strategies for patients.

Original research

Read the original publication and review its full methods and findings on PubMed.

MigraineMind is an educational resource designed to complement—not replace—the original scientific literature or clinical judgement. This page is an AI-generated summary of the available paper information and may contain errors. Please consult the original publication.